Abstract:ObjectivesSystemic lupus erythematosus (SLE) is a chronic relapsing autoimmune disease characterized by the presence of autoantibodies directed against nuclear antigens and by chronic inflammation. Although the etiology of SLE remains unclear, the influence of environment factors, which is largely reflected by the epigenetic mechanisms, with DNA methylation changes in particular, is generally considered as main players in the pathogenesis of SLE. We studied DNA methyltransferases’ (DNMTs) type 1, 3A and 3B transcript levels in peripheral blood mononuclear cells from patients diagnosed with systemic lupus erythematosus and from the healthy control subjects. Furthermore, the association of DNMT1, DNMT3A, and DNMT3B mRNA levels with gender, age, and major clinical manifestations was analyzed.MethodsPeripheral blood mononuclear cells (PBMCs) were isolated from 32 SLE patients and 40 healthy controls. Reverse transcription and real-time quantitative polymerase chain reaction (RT-qPCR) analyses were used to determine DNMT1, DNMT3A, and DNMT3B mRNA expression levels.ResultsSignificantly lower DNMT1 (p = 0.015543) and DNMT3A (p = 0.003652) transcript levels in SLE patients were observed compared with healthy controls. Nevertheless, the DNMT3B mRNA expression levels were markedly lower compared with DNMT1 and DNMT3A, both in PBMCs from affected patients and those from control subjects. Furthermore, the DNMT1 transcript levels were positively correlated with SLE disease activity index (SLEDAI) (rs = 0.4087, p = 0.020224), while the DNMT3A transcript levels were negatively correlated with patients age (rs = −0.3765, p = 0.03369).ConclusionsOur analyses confirmed the importance of epigenetic alterations in SLE etiology. Moreover, our results suggest that the presence of some clinical manifestations, such as phototosensitivity and arthritis, might be associated with the dysregulation of DNA methyltransferases’ mRNA expression levels.

The effect of ultraviolet ray exposure on DNA methylation in systemic lupus erythematosus

Effects of ultraviolet B exposure on DNA methylation in patients with systemic lupus erythematosus.

Ultraviolet B Enhances DNA Hypomethylation of CD4+ T Cells in Systemic Lupus Erythematosus Via Inhibiting DNMT1 Catalytic Activity

Ultraviolet B Decreases DNA Methylation Level of CD4+ T Cells in Patients with Systemic Lupus Erythematosus

DNA Methylation in Peripheral Blood Mononulclear Cells from Patients with Systemic Lupus Erythematosus

Abnormal Expression of Cd43 in Patients with Systemic Lupus Erythematosus and Its Clinical Significance

Associations between aberrant DNA methylation and transcript levels of DNMT1 and MBD2 in CD4+T cells from patients with systemic lupus erythematosus.

A study of genomic DNA methylation in patients with systemic lupus erythematosus

Expression of DNA methyltransferases and CD11a genes in systemic lupus erythematosus patients

Advances in Research on Relationship Between DNA Hypomethylation and Systemic Lupus Erythematosus

Activity of DNA Methyltransferase in Systemic Lupus Erythematosus

Role of DNA Methylation in the Pathogenesis of Systemic Lupus Erythematosus

Analysis of Associations Between the Patterns of Global DNA Hypomethylation and Expression of DNA Methyltransferase in Patients with Systemic Lupus Erythematosus

A Correlation Study on the Effects of DNMT1 on Methylation Levels in CD4(+) T Cells of SLE Patients.

Decreased mRNA expression levels of DNA methyltransferases type 1 and 3A in systemic lupus erythematosus

The study of DNA CpG methylation and lymphocyte function-associated antigen-1 expression in patients with systemic lupus erythematosus

Abnormal DNA Methylation in T Cells from Patients with Subacute Cutaneous Lupus Erythematosus.

Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis.

Diet, DNA methylation and systemic lupus erythematosus: evidence and perspectives focused on personalized nutrition

Significant heightened methylation levels of RUNX3 gene promoter in patients with systemic lupus erythematosus

Genomewide Analysis of 6-Methyladenine DNA in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus